Twice a year, the Charcot Foundation publishes a Bulletin which wants to be the objective reflection of research and last acquisitions in Multiple sclerosis as well in the field of our knowledge of the disease as of the new treatments under study

N° 56

OCTOBER 2024

• Multiple sclerosis - Live from the research front - October 2024
• Drug repurposing in MS, or how making something new out of the old
• Telemedicine in MS

Download pdf

N° 55

APRIL 2024

• Multiple sclerosis - Live from the research front
• The immune cell jungle in MS: could regulatory T cells show the way out?
• How to ensure therapeutic molecules penetrate the blood-brain barrier?

Download pdf

N° 54

OCTOBER 2023

• Pregnancy and multiple sclerosis: it’s not incompatible
• Planning a pregnancy: managing MS treatments
• Impact of pregnancy on the course of MS

Download pdf

N° 53

APRIL 2023

• Fundamental research: essential to achieving our objectives
• Remyelination of MS plaques: ultimate goal or illusion?
• Imaging remyelination in MS
• Measuring remyelination

Download pdf

N° 52

DECEMBER 2022

• We are all genetic mosaics
• The importance of papers in scientific and medical research

Download pdf

N° 51

APRIL 2022

• Optimise MS rehabilitation programmes
• MS rehabilitation: a lifelong "therapy"
• The impact of our donors on MS research

Download pdf

N° 50

OCTOBER 2021

• Brain imaging in multiple sclerosis, yes... but with some added nuances!
• MRI, a technological breakthrough for the diagnosis of MS
• MRI, a crucial tool for the diagnosis, prognosis and monitoring of patients
• Prof. Jean-Martin Charcot

Download pdf

N° 49

MARCH 2021

• The Charcot Fund 2020: Ensuring the continuity of research
• The Charcot Fund 2021: Opening the door to the future
• Are messenger RNA vaccines, a new weapon against infectious diseases and a source of hope for multiple sclerosis?

Download pdf

N° 48

NOVEMBER 2020

• Progress in MS Research
• The Charcot Fellowship 2020-2024

Download pdf

N° 47

APRIL 2020

• MS : Innovation and concrete results
• Rustproofing against MS
• A nasally administered drug
• Fundamental Research 2020
• Warning: MS and Corona virus
• Warning : Stem Cell Transplants

Download pdf

N° 46

NOVEMBER 2019

• Young people and Multiple Sclerosis
• Cannabis in the treatment of MS

Download pdf

N° B45

MAY 2019

• The future is taking shape
• Diagnostics: a clue in a blood sample
• An increase in the therapeutic arsenal against MS

Download pdf

N° B44

NOVEMBER 2018

• The new diagnostic criteria for Multiple Sclerosis
• The clinical subtypes of multiple sclerosis: a new classification.
• Charcot Fellowship 2018–2022

Download pdf

N° 43

MAY 2018

• A holistic approach to disease
• Physical and sport activities for multiple sclerosis patients

Download pdf

N° 42

NOVEMBER 2017

• Three weapons against MS
• Invisible and psychological complaints among people with MS
• The neurologist, first partner for patients suffering from MS
• BELTRIMS: Belgian national register for the treatment of MS
• Cell therapy

N° 41

MAY 2017

• Early diagnosis of multiple sclerosis
• Treatment of MS: sooner rather than later?

N° 40

NOVEMBER 2016

• Various stages of MS research
• Great progress in biomedical knowledge and development of new technologies
• Recent developments in MS research

N° 39

MAY 2016

• Smoking and Vitamin D deficiency, two harmful factors in multiple sclerosis.
• Oral treatments for multiple sclerosis

N° 38

NOVEMBER 2015

• MS affects more women than men
• Multiple sclerosis before the age of 18
• Effect of hormones

N° 37

MAY 2015

• Oligoclonal IgG bands : a persistent enigma
• Tribute to Dr Richard Gonsette
• Charcot Fund : testimony of Prof A. Goris
• In MS, the immune system also attacks the CNS cells.

N° 35

MAY 2014

• PIXAMS study : results
• The BELTRIMS registry
• New MRI study in MS planned by the Belgian MS Study Group
• Multiple sclerosis and children